YSB Inc. (HK:9885) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
YSB Inc. reports a robust first half of 2024, with revenue up by 10.6% and a significant turnaround to a profit of RMB 13.354 million from a substantial loss in the previous year. The company attributes its high-quality growth, with a total GMV increase of 8.1%, to policy support, technology empowerment, and an expanding outside-of-hospital pharmaceutical market. YSB Inc. also boasts a solid user ecosystem, highlighted by a 20.4% increase in monthly active buyers and a 93% paying ratio.
For further insights into HK:9885 stock, check out TipRanks’ Stock Analysis page.